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Abstract
Cell proliferation and differentiation are regulated in a highly coordinated and inverse manner during development and
tissue homeostasis. Terminal differentiation usually coincides with cell cycle exit and is thought to engage stable
transcriptional repression of cell cycle genes. Here, we examine the robustness of the post-mitotic state, using
Caenorhabditis elegans muscle cells as a model. We found that expression of a G1 Cyclin and CDK initiates cell cycle re-entry
in muscle cells without interfering with the differentiated state. Cyclin D/CDK4 (CYD-1/CDK-4) expression was sufficient to
induce DNA synthesis in muscle cells, in contrast to Cyclin E/CDK2 (CYE-1/CDK-2), which triggered mitotic events. Tissue-
specific gene-expression profiling and single molecule FISH experiments revealed that Cyclin D and E kinases activate an
extensive and overlapping set of cell cycle genes in muscle, yet failed to induce some key activators of G1/S progression.
Surprisingly, CYD-1/CDK-4 also induced an additional set of genes primarily associated with growth and metabolism, which
were not activated by CYE-1/CDK-2. Moreover, CYD-1/CDK-4 expression also down-regulated a large number of genes
enriched for catabolic functions. These results highlight distinct functions for the two G1 Cyclin/CDK complexes and reveal a
previously unknown activity of Cyclin D/CDK-4 in regulating metabolic gene expression. Furthermore, our data demonstrate
that many cell cycle genes can still be transcriptionally induced in post-mitotic muscle cells, while maintenance of the post-
mitotic state might depend on stable repression of a limited number of critical cell cycle regulators.
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Introduction
During the terminal stages of differentiation, cells usually arrest
proliferation and permanently exit the division cycle. Insight in
how this post-mitotic state is established and maintained is of both
fundamental and clinical importance. Entry into the cell cycle
requires activation of Cyclin Dependent Kinases (CDKs) in the G1
phase of the cell cycle. These kinases promote expression of cell
cycle genes that are controlled by E2F/DP (together named
‘‘E2F’’) transcription factors (for review: [1]). CDK inhibitors
(CKIs), such as p21
Cip1 and p27
Kip1, counteract cell cycle entry
through association with Cyclin/CDK complexes and inhibition
of their activity. In addition, members of the retinoblastoma
protein (pRb) family inhibit cell cycle entry through repression of
E2F-regulated cell cycle genes [2]. When activated in the G1
phase, Cyclin D/CDK4(6) and Cyclin E/CDK2 kinases phos-
phorylate pRb, which prevents its association with E2F and allows
activating E2F transcription factors to induce S phase gene
expression. Differentiation signals are thought to induce cell cycle
arrest through activation of negative regulators of G1 progression,
probably in parallel with chromatin remodeling and modification
complexes that induce stable repression of cell cycle genes [3–5].
Only a few examples have been reported of post-mitotic cells
that re-enter the cell cycle while maintaining the differentiated
state. In Drosophila, expression of E2F together with the Cdc25c
phosphatase String or Cyclin E/CDK2 induces continued division
of differentiated cells during eye and wing development [6]. In
mammals, loss of the pRb tumor suppressor allows proliferation of
certain terminally differentiated cells, such as the post-mitotic hair
cells of the mouse inner ear [7]. In addition, inactivation of pRb
family members can result in the development of retinoblastoma
or related tumors from fully differentiated neurons [8,9]. Thus, at
least some terminally differentiated cells that are normally arrested
can be induced to initiate cell proliferation with no apparent de-
differentiation.
In this study, we use the nematode C. elegans to examine the cell
cycle arrest associated with terminal differentiation. C. elegans
shows a tight inverse relationship between proliferation and
differentiation, and a highly reproducible pattern of terminal
differentiation [10,11]. Except for 55 ‘blast’ cells, all cells
differentiate and become post-mitotic before embryonic develop-
ment completes. The single Cyclin D (cyd-1) and CDK4/6 (cdk-4)
genes are essential for G1/S progression in postembryonic
development [12,13], while the single Rb-family member, lin-35,
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regulators of cell cycle entry [13–18]. Notably, lin-35 Rb
inactivation combined with cki-1/cki-2 inhibition causes only
limited over-proliferation in blast-cell lineages ([13], JK and SvdH,
unpublished observations). Thus, in C. elegans, cell cycle exit can
occur without a functional pRb family protein, as was recently also
observed in mice [19].
Here, we examine to what extent terminally differentiated C.
elegans body-wall muscle cells respond to, or resist, cell-cycle
inducing signals. Expression of G1 Cyclin/CDK combinations
triggered expression of S phase genes and partial cell cycle re-entry
in differentiated muscle cells, while not interfering with the
differentiation status. Tissue-specific transcriptional profiling and
single molecule FISH experiments revealed that CYD-1/CDK-4
and CYE-1/CDK-2 induce a substantial and overlapping set of
genes that are strongly associated with cell cycle functions.
However, CYD-1/CDK-4 also triggered up-regulation or down-
regulation of large numbers of genes with metabolism-associated
functions, and induced DNA replication, in contrast to CYE-1/
CDK-2. Notably, several key G1/S regulators, such as cye-1, cdc-
25.1, and cdk-2, were not induced by CYD-1/CDK-4. Thus,
differentiated muscle cells remain remarkably flexible for cell cycle
induction, while at the same time, robust repression of a few key
regulators appears to maintain a stable post-mitotic state.
Results
G1 Cyclin/CDK induction overcomes cell cycle
quiescence
We set out to examine if cell cycle entry can be induced by
transcriptional induction of single G1 Cyclins (CYD-1 Cyclin D or
CYE-1 Cyclin E), CDKs (CDK-4, CDK-2, or CDK-2AF, a
mutated form of CDK-2 that lacks the negative Tyr14 and Thr15
phosphorylation sites), or combined expression of CYD-1/CDK-
4, CYE-1/CDK-2 or CYE-1/CDK-2AF. We first examined the
effects of G1 Cyclin/CDK transgene expression in cells that are
temporarily arrested (quiescent) but not terminally differentiated.
In wild-type larvae that hatch from the egg, precursor cells of the
post-embryonic lineages remain quiescent under starvation
conditions. When food is added, development resumes and
postembryonic blast cells initiate proliferation [14]. Expression of
any of the three Cyclin/CDK combinations from the intestine-
specific elt-2 promoter prevented the normal cell cycle arrest in the
intestine of late embryonic and starved L1 animals (see Figure S1).
Based on BrdU incorporation, DNA replication continued in
starvation-arrested larvae with intestinal Cyclin/CDK expression
(Figure S1D). The number of intestinal nuclei in these starved L1
animals regularly exceeded the maximal number of 34 nuclei in
normal adults (Figure S1B and S1F). Expression of either CYD-1
or CYE-1 alone was sufficient to trigger nuclear division and DNA
replication, whereas CDK expression alone did not induce an
apparent cell cycle response (Figure S1E and S1F; and data not
shown). This probably indicates that the temporally arrested cells
contain residual CDK proteins, but not G1 Cyclins. We conclude
that transcriptional induction of a G1 Cyclin is sufficient to
prevent cell cycle quiescence of intestinal cells.
Cyclin/CDK expression in muscle leads to cell cycle re-
entry during larval development
Next, we examined if G1 Cyclin/CDK expression could trigger
cell cycle re-entry in terminally differentiated body-wall muscle.
The C. elegans larva is born with 81 fully differentiated body-wall
muscle cells [10]. We chose the myo-3 promoter (Pmyo-3) to drive
expression of Cyclins and CDKs in muscle, as the muscle myosin
gene myo-3 is turned on in post-mitotic embryonic body-wall
muscle [20,21]. When expressed from this promoter, CYE-1 and
CDK-2AF showed muscle-specific expression in immunostaining,
and complex formation in immunoprecipitation/western blotting
experiments (Figure S2). Next, we introduced the different Cyclin/
CDK combinations together with a reporter construct, Pmyo-
3::GFP::H2B, to facilitate the detection of muscle nuclei, and
generated strains with integrated arrays to avoid mosaic expression
(Figure 1A).
In contrast to our findings in the intestine, animals expressing
any of the three Cyclin/CDK combinations in muscle hatched
with a normal complement of muscle nuclei (Figure S3A and S3B).
Thus, Pmyo-3-driven Cyclin/CDK expression does not lead to
extra muscle cell division during embryogenesis. However, from
the L2 stage onwards, some body-wall muscle cells started to show
signs of mitosis, including chromosome condensation, chromo-
some congression, anaphase and nuclear division, sometimes even
resulting in clusters of small nuclei (Figure 1B; Figure S3C-S3E). In
contrast to quiescent intestinal cells, expression of CYD-1 or CYE-
1 alone did not induce mitotic events in differentiated muscle cells.
CYE-1/CDK-2AF was much more efficient in inducing mitotic
events than CYD-1/CDK-4, while CYE-1/CDK-2WT expres-
sion gave an intermediate effect (Figure 1C). Western blotting
experiments indicated that the extent of mitotic induction did not
correspond to the protein expression level, but rather the type of
CDK (and Cyclin) expressed (Figure S4). The combination of
CYD-1/CDK-4 and CYE-1/CDK-2AF caused the strongest
mitotic induction (Figure 1C).
We looked for additional indications of cell cycle re-entry in
body-wall muscle cells. Staining for the mitosis specific phospho-
histone H3S10 epitope readily visualized mitotic nuclei in the
body-wall muscle of CYE-1/CDK-2AF animals (Figure 2A and
2B). Moreover, we observed expression of S-phase reporters in
muscle cells. One of these reporters uses the rnr-1 ribonucleotide
reductase promoter to express tdTomato in frame with a
destruction box containing N-terminal CYB-1 Cyclin B fragment
[22]. In addition, we used a transgenic strain with a single-copy
translational fusion of C. elegans MCM-4::mCherry under its native
Author Summary
During development, cells face the important decision
whether to continue to proliferate, or to exit the cell-
division cycle and fully differentiate. Improved insight into
the molecular mechanisms that arrest the cell cycle during
terminal differentiation is important for our understanding
of normal development, as well as for cancer research and
regenerative medicine. To investigate the arrested state of
terminally differentiated cells, we examined muscle cells in
the model organism C. elegans, which is known for its
reproducible cell-division pattern. We found that expres-
sion of a single cell cycle kinase with its regulatory partner
(Cyclin) induced many cell division genes in muscle. While
Cyclin D and E kinases often act similarly, only Cyclin D
with CDK-4 triggered DNA replication in muscle, and this
combination induced a much broader transcriptional
response than Cyclin E/CDK-2. Despite activation of a
substantial cell cycle program, Cyclin/CDK expression did
not induce complete muscle cell division and failed to
induce some key cell cycle regulators. Our results highlight
distinct activities of Cyclin D and Cyclin E kinases, and they
indicate that cell-cycle gene expression remains remark-
ably flexible in differentiated cells. We propose that the
post-mitotic state of differentiated cells is maintained by
tight control of a few regulatory genes.
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muscle of normal larvae. In contrast, MCM-4::mCherry was
detectable as early as the L1 stage in all body-wall muscle cells of
CYD-1/CDK-4 and CYE-1/CDK-2AF-expressing animals
(Figure 2C and 2D, and data not shown). Expression of rnr-
1::CYB-1desBox::tdTomato became detectable from the L2 stage
onward, and even remained detectable in the muscle of adult
animals.
Importantly, heat-shock promoter driven expression of CYD-1
and CDK-4 during larval development also induced S-phase
reporter gene expression. After heat shock, we observed MCM-
4::mCherry expression in the body-wall muscle of hsp-16.2::CYD-
1/hsp-16.2::CDK-4 transgenic strains (Figure 2E and 2F; in 3 of 3
strains), but never in control heat-shock treated animals without
the Cyclin/CDK transgenes (n=50 animals examined). Even
adult animals showed MCM-4 expression after heat-shock
induction of CYD-1 and CDK-4, further illustrating that the S
phase reporter could be turned on after terminal differentiation.
Together, these results indicate that at least some cell cycle genes
are not irreversibly silenced in post-mitotic muscle cells.
C. elegans Cyclin D/CDK-4, but not Cyclin E/CDK-2,
induces S phase in muscle cells
Next, we tested if G1 Cyclin/CDK expression is sufficient for
induction of DNA replication in differentiated muscle cells. We
used two independent methods to detect DNA synthesis. First, we
examined incorporation of EdU, a thymidine analogue that can be
used to visualize DNA replication in combination with antibody
staining of muscle nuclei [22,23]. We stained L4 animals for both
EdU and GFP and analyzed muscle cells anterior of the vulva, to
exclude muscles formed in the postembryonic Mesoblast lineage.
To our surprise, only in 2 out of 35 CYE-1/CDK-2AF expressing
animals EdU incorporation was detectable in a few muscle cells,
while all other muscle nuclei were completely EdU negative
(Figure 3C and 3D, circles). In contrast, the anterior of more than
half (19/35) of the CYD-1/CDK-4 animals contained clearly EdU
positive body-wall muscle cells (Figure 3A and 3B, arrowheads).
Quantitative determination of DNA content based on propi-
dium iodide (PI) intercalation confirmed and expanded these
results (Figure 3E). While body-wall muscle in the Pmyo-
3::H2B::GFP control strain showed a G1 DNA content (2n),
muscle cells with CYD-1/CDK-4 expression often contained a
larger amount of DNA, which corresponded to a partly or
completely duplicated genome (4n). CYE-1/CDK-2 expressing
muscle cells did not contain more than 2n DNA, and very few
muscle cells with combined expression of CYD-1/CDK-4 and
CYE-1/CDK-2 contained 4n DNA (Figure 3E). Thus, CYD-1/
CDK-4 promotes DNA replication, while CYE-1/CDK-2 even
appears to inhibit induction of DNA synthesis by CYD-1/CDK-4.
Together, CYE-1/CDK-2AF expression in differentiated muscle
triggers S-phase gene expression and mitosis, but not DNA
replication, while the CYD-1/CDK-4 combination induces a
more normal cell cycle that includes DNA replication in S phase,
but usually arrests prior to M phase.
Activation of a cell-cycle transcriptional program without
loss of muscle differentiation
Our combined data indicate that differentiated body-wall
muscle cells can re-enter the cell cycle post-embryonically in
response to G1 Cyclin/CDK expression. Next, we wanted to
examine if the observed cell cycle re-entry coincides with loss of
muscle differentiation. Animals expressing G1 Cyclin/CDK
complexes in the body-wall muscle appear phenotypically normal
and show apparently normal sinusoidal movement (Figure 4C). To
examine muscle structure, we stained animals for UNC-15/
Paramyosin, a component of thick muscle filaments in C. elegans
Figure 1. G1 Cyclin/CDK expression induces mitotic events in body-wall muscle cells. (A) Control animal expressing the GFP::H2B fusion
protein in body-wall muscle. (B) Animals that express CYE-1, CDK-2AF and GFP::H2B together from the myo-3 promoter show chromosome
condensation (arrow) and nuclear division (arrowhead) in differentiated body-wall muscle. (C) Quantification of mitotic events for each Cyclin/CDK
combination at the L3 stage. Each dot represents the number of mitotic muscle nuclei (with condensed DNA, metaphase or anaphase figures or
nuclear division) in a single animal. In each animal, 58 muscle nuclei anterior of the prospective vulva were counted, to exclude muscle cells formed
during post-embryonic development in the Mesoblast lineage. The highest mitotic index was 12% (7/58) in the strain with both Cyclin/CDKs. Error
bars represent S.E.M.
doi:10.1371/journal.pgen.1002362.g001
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displayed a normal pattern of thick muscle filaments, even when
nuclei with clear mitotic figures were present (Figure 4A and 4B).
These data support the idea that CYE-1/CDK-2AF expression
does not change muscle structure and function.
To obtain a more comprehensive picture of the changes
induced by CYD-1/CDK-4 and CYE-1/CDK-2AF expression,
we performed tissue-specific mRNA profiling of body-wall
muscles. Key to this approach is muscle-specific expression of a
FLAG-tagged PAB-1 poly(A)-binding protein [25]. As a validation
of the method, immunopurification of PAB-1-crosslinked mRNA
from Pmyo-3::FLAG::PAB-1 transgenic animals yielded mRNAs
that were highly enriched for muscle-expressed genes (Table S1).
We next compared the mRNA profiles of control L1 animals
(carrying the Pmyo-3::GFP::H2B and Pmyo-3::FLAG::PAB-1 trans-
genes), and L1 animals that, additionally, expressed CYE-1/CDK-
2AF or CYD-1/CDK-4 in muscle cells. Most genes in CYD-1/
CDK-4 or CYE-1/CDK-2AF expressing muscle cells were not
significantly up- or down- regulated (Figure S5A and S5B, Table
S2). This includes nearly all muscle-specific genes, confirming
maintenance of the muscle-specific fate (see below).
A set of 219 genes was significantly upregulated (fold-change $
2, p,0.05) in CYE-1/CDK-2AF animals compared to the
control strain. Manual annotation of these induced genes and
GO-term enrichment analysis using Funcassociate [26] revealed
a large overrepresentation of genes involved in various aspects of
the cell cycle, including G1/S regulation, DNA replication, DNA
damage response, mitosis, cytokinesis and checkpoint control
(Figure 5B and 5E, Table S2). Similar to CYE-1/CDK-2AF,
CYD-1/CDK-4 expression in the body-wall muscle induced a
set of 395 genes with a strong cell cycle signature (Figure 5A,
Table S2).
The majority of genes upregulated in CYE-1/CDK-2AF were
also upregulated in CYD-1/CDK-4 muscle (Figure 5C and 5D).
The overlapping gene set has a particularly strong cell cycle
signature, with over 60% of the genes with functional annotations
in a cell cycle category (Figure 5D and 5E). Interestingly, CYD-1/
CDK-4 also induced a set of 143 genes (. 2x, p,0.05) that are
not significantly upregulated by CYE-1/CDK-2AF expression
(p.0.05) (Table S2, Table S3). These genes were enriched for GO
terms related to biosynthesis, though at adjusted P values slightly
above 0.05 (0.055 to 0.092). Manual annotation confirmed that
many of these genes (45 of 87 genes with recognizable
homologues) have ascribed cellular growth and metabolism
functions (Figure 5A, Table S2). This suggests that CYD-1/
CDK-4 does not only activate a cell-cycle transcriptional program,
Figure 2. G1 Cyclin/CDK expression induces S and M phase markers in larval muscle. (A,B) A body-wall muscle cell expressing CYE-1/CDK-
2AF stains positive for the mitosis-specific phospho-histone H3S10 epitope (arrow). (C,D) Expression of the S-phase marker Pmcm-4::MCM-4::mCherry
(MCM4) in all body-wall muscle cells of an adult animal expressing CYD-1/CDK-4 from the myo-3 promoter. (D) merged image of MCM-4::mCherry,
GFP::H2B and DIC. (E,F) Expression of the Pmcm-4::MCM-4::mCherry S-phase marker in an L4 animal after heat-shock induced expression of CYD-1/
CDK-4 at the L2/L3 stage. (F) merged image of MCM-4::mCherry and DIC. Arrows point to muscle nuclei, scale bars indicate 10 mm.
doi:10.1371/journal.pgen.1002362.g002
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metabolism associated gene expression.
A major function of G1/S Cyclin/CDK complexes is the
activation of E2F transcription factors through inhibitory phos-
phorylation of pRb proteins [1]. We therefore analyzed the
promoter sequences of genes upregulated in CYD-1/CDK-4 or
CYE-1/CDK-2AF for enrichment in consensus transcription
factor binding sites (Materials and Methods), including a C. elegans
specific profile for the EFL-1 (E2F) transcription factor [27]. We
analyzed the promoter regions of 439 genes upregulated $ 2 fold
Figure 3. C. elegans Cyclin D/CDK-4 induces DNA replication in muscle. (A-D) Detection of EdU incorporation in body-wall muscle nuclei.
(A,C) EdU staining, (B,D) merged image of EdU, GFP and DAPI staining. EdU-positive nuclei are readily detectable in CYD-1/CDK-4 expressing body-
wall muscle (A, arrowheads), but not in CYE-1/CDK-2AF expressing body-wall muscle (C, circles). For comparison, the arrow in (A) indicates a Pn.p cell,
which completed one round of DNA replication in the presence of EdU. (E) Quantitative determination of DNA content reveals DNA replication in
CYD-1/CDK-4 expressing muscle cells. Each dot indicates the DNA content, based on propidium iodide staining, of a single body-wall muscle nucleus.
Pn.p nuclei in the ventral cord were used as 2n controls. L3/L4 stage larvae were stained in A-D, GFP staining reveals muscle expressed GFP::H2B and
CDK-2/4::Venus.
doi:10.1371/journal.pgen.1002362.g003
Figure 4. Animals with mitotic body-wall muscle retain normal motility and muscle structure. (A,B) UNC-15/Paramyosin staining (red) of a
control (Pmyo-3::GFP::H2B) line and a line with muscle expression of CYE-1 and CDK-2AF. Arrows mark GFP (green) expressing nuclei of body-wall
muscle cells. (B) Body-wall muscle in both animals show thick filament structures, despite the signs of mitosis (arrows). (C) Motility assay of L4 larvae:
N2 wild type, SV858 (Pmyo-3::CYE-1/CDK-2AF) and SV859 (Pmyo-3::GFP::H2B control). Each dot represents a single animal. Error bars represent S.E.M.,
scale bars indicate 10 mm.
doi:10.1371/journal.pgen.1002362.g004
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both sets of promoters the highest scoring transcription factor site
motif was that of E2F1, while the C. elegans specific EFL-1 site
ranked fifth and third respectively (Table S4). These results are
consistent with the activation of a set of E2F target genes by both
CYD-1/CDK-4 and CYE-1/CDK-2. We next analyzed the 143
genes upregulated in CYD-1/CDK-4 animals but not in CYE-1/
CDK-2 animals. This set of genes was hardly enriched for E2F1
and EFL-1 sites (Table S4). Together with the functional
annotations, these results indicate that CYD-1/CDK-4 and
CYE-1/CDK-2 induce a core set of E2F regulated cell cycle
genes, while CYD-1/CDK-4 also activates a set of genes with a
broader range of functions.
CYE-1/CDK-2 expression in muscle caused down-regulation of
only 50 genes with no functional enrichment. In contrast, CYD-1/
CDK-4 expression also resulted in down-regulation ($ 2x,
p,0.05) of a substantial set of 555 transcripts (Table S5). This
group shows a remarkable enrichment with GO terms related to
catabolic processes, including peptidase, lipase, esterase and
hydrolase activities. While muscle cells remain functional and
morphologically normal, 60 of the down-regulated genes are
normally highly expressed in muscle (Table S4). Thus, CYD-1/
CDK-4 causes upregulation of cell-cycle and biosynthesis-
associated genes, as well as down-regulation of genes primarily
associated with biodegradation and energy production.
Key G1/S regulators are not induced by G1 Cyclin/CDK
expression in muscle
Despite the robust induction of many E2F targets, some key
activators of G1/S progression were not induced. For instance, in
Figure 5. Microarray analysis reveals induction of cell-cycle gene transcripts in differentiated muscle cells. (A,B) Functional annotation
of genes significantly increased more than 2-fold in Pmyo-3::CYD-1/CDK-4 and Pmyo-3::CYE-1/CDK-2AF muscle cells. A large overrepresentation of
genes involved in various stages of the cell cycle is seen in both data sets, as well as a distinct increase in the proportion of metabolism and signaling
genes in CYD-1/CDK-4 animals. (C) Overlap in more than 2-fold upregulated genes between CYE-1/CDK-2AF and CYD-1/CDK-4 body-wall muscle cells.
The majority of the genes induced by CYE-1/CDK-2AF are also induced in CYD-1/CDK-4, but the latter also contains a substantial number of non-cell
cycle genes. (D) Functional annotation of the genes present in the overlap between CYD-1/CDK-4 and CYE-1/CDK-2AF reveals a strong (60%)
representation of known cell cycle genes. (E) Table of representative cell cycle genes and their orthologs that are induced by both CYD-1/CDK-4 and
CYE-1/CDK-2AF (.2-fold upregulated).
doi:10.1371/journal.pgen.1002362.g005
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mean of 4 experiments) was 0.11 for cye-1 Cyclin E, 0.04 for cdk-2,
and -1.3 for cdc-25.1. These genes are well-established E2F targets
in mammals, Drosophila, and, at least cye-1 and cdc-25.1, also in C.
elegans [27,28]. These observations suggest that in contrast to many
other E2F targets, the actual regulators that promote cell cycle
entry may be more tightly repressed.
We used single molecule FISH analysis to verify the gene
expression analysis. This method makes use of approximately 48
individually labeled short oligonucleotide probes, which together
allow detection of individual mRNA molecules [29]. As a first test,
we examined myo-3 mRNA abundance. The control strain,
expressing myo-3::H2B::GFP in muscle, and four different strains
with muscle-induced G1 Cyclin/CDK expression, all showed
readily detectable fluorescent myo-3 mRNA spots in the cytoplasm
of muscle cells (Figure 6A–6C, 6G). Very similar numbers were
obtained in different strains and experiments; illustrating that
single molecule FISH gives reproducible results (Figure 6G, and
data not shown). Next, we used this technique to examine mRNA
levels of the E2F-target mcm-6. All muscle cells with G1 Cyclin/
CDK expression showed substantial mcm-6 mRNA induction as
early as 3 hrs of postembryonic L1 development, in agreement
with the microarray data (Figure 6H). Induction of mcm-6 was
observed in CYE-1/CDK-2AF and CYE-1/CDK-2 expressing
strains, and in two independent CYD-1/CDK-4 strains, including
one with low levels of CYD-1/CDK-4 expression in muscle (CYD-
1/CDK-4 #2; Figure 6H, Figure S4).
The microarray data showed weak upregulation of the Leucyl
amino-acyl tRNA synthetase gene lrs-2 in muscle with CYD-1/
CDK-4 (induction factor 1.38) but not in CYE-1/CDK-2AF
expressing muscle (induction 0.04). FISH experiments showed the
same trend: strain 2 with only low CYD-1/CDK-4 expression
showed lrs-2 upregulation, while even the high CYE-1/CDK-2
expressing strain did not differ from the control (Figure 6I). In
contrast, cye-1 mRNA was nearly absent in CYD-1/CDK-4
expressing muscle cells, with occasionally a single or at most two
small dots in muscle cells (Figure 6E, 6J). Thus, the single molecule
FISH experiments support our conclusions from the microarray
data, and show with single cell resolution that cye-1 mRNA
expression is not even induced in a subset of muscle cells.
Discussion
In this study, we demonstrate that post-mitotic C. elegans muscle
cells remain remarkably competent to express cell cycle genes, and
that cell cycle re-entry can occur coincident with the differentiated
state. In addition, we demonstrate differential activity of CYD-1/
CDK-4 versus CYE-1/CDK-2 in the regulation of gene
expression. These results challenge prevailing views on the
irreversible commitment to cell cycle exit upon terminal
differentiation and the linear pathway of CDK activities.
Figure 6. Single molecule FISH shows gene expression in individual muscle cells and limited cye-1 induction by CYD-1/CDK-4. (A-F)
Single mRNA molecules labeled with probes against myo-3 (blue) or cye-1 (red) mRNA. Muscle nuclei are marked in green by myo-3::H2B::GFP.
Analyzed are strains expressing only Pmyo-3::H2B::GFP (control, SV859: A-D), and Pmyo-3::H2B::GFP together with Pmyo-3::CYD-1/CDK-4 (SV857: E) or
Pmyo-3::CYE-1/CDK-2AF (SV858: F). Arrowheads indicate areas of myo-3 mRNA (C) or cye-1 mRNA (E, F) expression in dorsal body-wall muscle cells.
Arrows in (D-F) indicate cye-1 expression in the gonad. Scale bar indicates 10 mm, all panels show the same magnification. (G-J) Quantification of the
number of fluorescent spots in seven body-wall muscle cells located anterior of the gonad on the dorsal side of animals. All animals were hybridized
with myo-3 probes to identify body-wall muscle cells. Signal corresponding to mRNA molecules of myo-3 (G), mcm-6 (H), lrs-2 (I), or cye-1 (J) were
counted. The strains analyzed are SV859 (control), SV857 (cyd-1/cdk-4 #1), SV860 (cyd-1/cdk-4 #2), SV858 (cye-1/cdk-2AF) and SV861 (cye-1/cdk-2WT).
Note that overlap between spots greatly reduced the counted number of myo-3 and mcm-6 mRNAs. In contrast, the few and small cye-1 labeled spots
are likely all single mRNA molecules.
doi:10.1371/journal.pgen.1002362.g006
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CYD-1/CDK-4 complex controls expression of metabolic genes,
in addition to cell cycle genes. These transcriptome data fit well
with observations that Cyclin D is directly controlled by mitogenic
signals as the most upstream regulator in cell cycle entry (reviewed
in [30]), and that Drosophila Cyclin D and Cdk4 predominantly act
to promote growth rather than cell cycle progression [31,32].
While many studies implicate Cyclin D and Cyclin E CDKs as
regulators of the Rb/E2F module, our data provide strong support
for CYD-1/CDK-4 control of additional transcription factors.
Interestingly, Cyclin D has been observed to interact with several
transcriptional regulators, to localize to promoters, and to affect
transcription independently of CDK4/6 (e.g., [33]). It will be of
great interest to find if these results relate to our observations, and
what molecular mechanisms underlie the regulation of metabolic
genes by Cyclin D/CDK4. As a potential substrate, several
metabolic genes that are specifically up-regulated (e.g., acs-2)o r
down-regulated (e.g., ech-9/F01G10.3) by CYD-1/CDK-4 are
transcriptional targets of NHR-49, a member of the Hepatocyte
Nuclear Factor 4 (HNF4) family of nuclear hormone receptors
[34].
CYD-1/CDK-4 also induced DNA replication in muscle, while
CYE-1/CDK-2, in contrast, appeared to antagonize DNA
synthesis. As a possible explanation, DNA synthesis might depend
on a growth-related signal that is uniquely induced by CYD-1/
CDK-4. Alternatively, or in addition, the different effects of the
two Cyclin/CDK combinations may result from different roles in
DNA replication origin licensing. CYE-1/CDK-2 antagonizes the
formation of DNA pre-replication complexes (pre-RCs), at least in
some cell types [35-37]. This activity helps to restrict DNA
replication to only once per cell cycle. The observed induction of
DNA replication in muscle cells indicates that CYD-1/CDK-4
does not share this CYE-1/CDK-2 function, but allows the
formation and function of pre-RCs. In arrested intestinal cells,
CYE-1 Cyclin E was sufficient to induce DNA replication, which
points to an important difference in the arrested state of quiescent
versus post-mitotic cells.
Progression from temporary arrest to irreversible cell cycle exit
is thought to depend on epigenetic silencing of cell cycle promoters
(e.g., [3]). Our transcriptional profiling indicates that such a
repressive chromatin state can be reversed at many cell cycle
promoters. As Cyclin/CDK expression does not appear to induce
full cell division of body-wall muscle, additional safeguards
probably inhibit proliferation. Our expression studies indicate
that these safeguards focus on a limited number of critical
regulators. Interestingly, expression of E2F in differentiating
Drosophila eye and wing cells, and differentiation of mouse Rb-
family triple knockout cells have also revealed additional levels of
control that impinge on Cyclin E during terminal differentiation
[19,38].
Coincident differentiation and proliferation has been observed
in some situations, such as proliferating horizontal interneurons in
mouse retinoblastoma, proliferating pRb(-/-) hair cells of the
mouse inner ear, and Drosophila wing hairs and eye cells expressing
E2F and Cyclin E [6-8]. Our preliminary results indicate that
CYD-1/CDK-4 expression also triggers S phase gene expression
in differentiated C. elegans neurons (data not shown). Together, the
different examples indicate potential for finding a common set of
gene alterations that can induce cell proliferation in terminally
differentiated cells. Despite the success of induced pluripotent stem
cells, this could ultimately provide an attractive regeneration
strategy, in particular if limited proliferation could be achieved
without genome-wide remodeling of the chromatin and loss of the
differentiated state.
Materials and Methods
Strains, molecular cloning, and transgenes
All strains and culture conditions are listed in Text S1.
Expression constructs for cye-1, cyd-1, cdk-4, cdk-2, cdk-2AF, and
GFP::H2B were created using a 2.4 Kb myo-3 promoter (PCGS1
(Pmyo-3), body-wall muscle expression) or a 5 kb elt-2 promoter
(intestinal expression [39]). Coding sequences of Venus YFP with
C. elegans-optimized codons (a kind gift of Yuichi Iino) were
inserted before the translational stop in all CDK constructs. The
CDK-2AF mutant was created by mutating two conserved Wee1
phosphorylation sites (Thr25-to-Ala and Tyr26-to-Phe) by site-
directed mutagenesis. Pmcm-4::MCM-4::mCherry::mcm-4 39UTR was
recently described [22] and integrated as a single copy using the
MosSCI technique [40]. The Prnr::CYB-1DesBox::TdTomato marker
expresses an N-terminal 100 amino acid part of C. elegans CYB-1
(N-CYB-1), which harbors a KEN destruction box sequence for
recognition by the APC/C coupled to the TdTomato fluorophore
[22]. Multiple transgenic lines were analyzed for each Cyclin/
CDK combination. Representative lines with 40-70% F2
transmission were selected for c-irradiation. Integrated lines were
backcrossed with N2 a minimum of 4 times before analysis.
Immunostaining and detection of DNA replication
For immunostaining of larval stages, animals were fixed in
methanol (5 min. at 220uC) and acetone (20 minutes at 220uC)
according to [22]. BrdU and EdU staining were performed as
described [22,41]. Primary antibodies used: rabbit anti-phospho-
H3S10 (1:200, Abcam), mouse anti-GFP (1:100, Sigma), mouse
anti-CYE-1 (E. Kipreos, 1:200), rabbit anti-GFP (1:100, Molecular
Probes), mouse monoclonal antibody 5-23 to UNC-15 (1:3, tissue
supernatant, Developmental Studies Hybridoma Bank). Second-
ary antibodies used: Donkey anti-mouse FITC or TexasRed and
Donkey anti-rabbit FITC or TexasRed (1:200, Jackson Immuno-
laboratories).
Quantitative DNA measurements were performed as previously
described [41]. In short, series of Z-sections were taken of
propidium iodide-stained animals with a confocal scanning laser
microscope, and pixel intensities of all sections were added and
recalculated to DNA content, using Pn.p ventral cord precursor
nuclei as a 2n DNA standard.
Tissue-specific microarray analysis
Tissue-specific mRNA was isolated from synchronized L1
larvae fed for 3 hours by purification of the poly-A binding
protein FLAG::PAB-1 specifically expressed in body-wall muscle
cells of L1 larvae [25]. Poly(A)
+ RNA was isolated essentially as
described [25]. Four independently grown biological samples were
used for each different line: SV912 (control), SV911 (CYE-1/CDK-
2AF), and SV985 (CYD-1/CDK-4). Array data is submitted to
ArrayExpress accession no.: E-TABM-886. Procedures used in the
hybridizations, data analysis and transcription factor analysis are
detailed in Text S1.
Functional analysis
Manual annotation of genes upregulated .2-fold was done
using WormBase (release WS207). GO-term enrichment was
determined using Funcassociate [26].
Single-molecule Fluorescence In Situ Hybridization
Single molecule Fluorescence In Situ Hybridization was
performed as described by [29]. Starved L1 animals were fed for
three hours on OP50, followed by fixation in 4% formaldehyde
and hybridization with sets of the 48 labeled oligonucleotide
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microscope, quantification of the number of mRNAs was
performed using the 3D imaging software Volocity version 5
(Perkin Elmer). For quantification, a region of interest was drawn
around seven body-wall muscle nuclei, located anteriorly from
the gonad on the dorsal side of the animal, to exclude cells in the
ventral nerve cord and mesoblast lineage. Further details on
the procedure, microscopy and data analysis are provided in
Text S1.
Supporting Information
Figure S1 Expression of G1 Cyclin/CDK combinations in the
intestine of arrested L1 larvae leads to extra nuclear divisions and
DNA synthesis. (A-B) L1 animals carrying an integrated Pelt-
2::GFP marker alone (A) or in combination with CYD-1/CDK-4
expressed from the intestinal elt-2 promoter (B). Arrows indicate
clusters of extra nuclei. (C-D) BrdU incorporation in the intestine
of wild-type starved L1 control animals (C) or animals expressing
CYD-1/CDK-4 in the intestine (D). Control L1 arrested animals
have no BrdU positive intestinal cells, only the Q neuroblast
daughters (C, brackets) and some epidermal V-cells occasionally
escape arrest. The intestine of the Pelt-2::CYD-1/CDK-4 animal
shows an extensive amount of intestinal cells that have undergone
DNA replication during starvation induced quiescence (D,
arrows). (E) Quantification of the percentage of animals staining
positive for BrdU in the gut in representative lines of each Cyclin/
CDK combination. (F) Quantification of the number of intestinal
nuclei in arrested L1 animals. Note that expression of CYD-1
alone is sufficient to trigger cell-cycle progression in the gut. Each
dot represents a single animal. Error bars represent S.E.M.
(TIF)
Figure S2 Expression of CYE-1 and CDK-2AF::Venus in the
body wall muscle. A-C: Immunostaining of CYE-1 and GFP in
SV858 (Pmyo-3::GFP::H2B; Pmyo-3::CYE-1/CDK-2AF::Venus)L 1
larva. GFP antibody staining visualizes the body wall muscle
nuclei (A), the CYE-1 staining shows nuclear localization of CYE-
1 protein in the body wall muscle (B) C: Merge of (A) and (B). D:
Immunoprecipitation (IP) of the CYE-1/CDK-2AF::Venus com-
plex. CYE-1 migrates with an apparent molecular weight of ,72
kDa. The CDK-2AF::Venus fusion protein is detected at 66 kDa
with anti-GFP antibodies. The CYE-1/CDK-2AF::Venus inter-
action was detected in both the CYE-1 and GFP immunoprecip-
itations.
(TIF)
Figure S3 Body wall muscle expressing CYE-1/CDK-2AF show
mitotic events during larval development. (A) GFP-DIC picture of
a starvation-arrested L1 animal expressing CYE-1/CDK-2AF
from the myo-3 promoter. No extra nuclei or mitotic nuclei are
observed at this stage. (B) Quantification of muscle nuclei in
control animals (expressing only Pmyo-3:GFP::H2B in their muscle)
and CYE-1/CDK-2AF L1 animals after 24 or 48 hours of L1
arrest. N=15 animals for each condition. Each dot represents a
single animal. Error bars represent S.E.M. (C, D, E) During larval
development, mitotic body wall muscle nuclei become apparent.
L3 stage animals that express Pmyo-3::CYE-1, Pmyo-3::CDK-2AF
and Pmyo-3::GFP::H2B show DNA condensation (C, D, arrow-
heads) and abnormal nuclear divisions (D,E, arrows) in differen-
tiated body wall muscle.
(TIF)
Figure S4 Western blot analysis of CDK and H2B expression
levels in transgenic strains. Total protein lysates of transgenic
animals with muscle expression of GFP::H2B alone (control,
SV859), or together with Cyclin D/CDK-4::Venus (SV857: cyd-1/
cdk-4 #1, SV860: cyd-1/cdk-4 #2) or Cyclin E/CDK-2::Venus
(SV858: cye-1/cdk-2AF, SV861: cye-1/cdk-2WT) were separated by
SDS PAGE electrophoresis and blotted. The upper panel was
probed with an anti-GFP antibody and shows CDK-2/4::Venus
(70 and 66 kDa resp., upper arrow) and GFP::H2B (41.5 kDa,
lower arrow) protein bands. The lower panel contains the same
samples, probed with anti-a-Tubulin (55 kDa) as a loading control
(arrow points to a-Tubulin). Note that the cyd-1/cdk-4 #1 strain
shows higher levels of transgene expression than the cye-1/cdk-2AF
strain. These strains were used in all subsequent experiments,
except for cyd-1/cdk-4 #2, which was only used in the experiments
shown in Figure 6.
(TIF)
Figure S5 Scatterplot representation of expressed genes. (A,B)
Microarray signal intensities for CYE-1/CDK-2AF (A) and CYD-
1/CDK-4 (B) expressing muscle compared to control muscle IP
(SV912). The experiment was repeated four times for each line.
The intensities of all genes are shown after background
subtraction, normalization, and merging of replicate culture dye-
swap hybridizations. MAANOVA statistical analysis was per-
formed to determine genes with significantly different mRNA
expression. White data points mark genes that are significantly
changed (p,0.05) and have a $2-fold change. Values are plotted
on a log10 scale. Y-axis: CYD-1/CDK-4 (SV985) or CYE-1/
CDK-2AF (SV911) PAB-1 IP RNA versus total RNA, X-axis:
Control (SV912) PAB-1 IP RNA versus total RNA. (C) Plot of
significantly changed genes (p# 0.05) in CYE-1/CDK-2AF (Y-
axis) and CYD-1/CDK-4 (X-axis). Colors for each data point
indicate in which set(s) the gene is significantly changed (green:
CYD-1/CDK-4, red: CYE-1/CDK-2AF). Values are plotted on a
log2 scale.
(TIF)
Table S1 List of genes enriched $2-fold in muscle (PAB-1 IP
versus total RNA) and GO-term analysis of these genes. The
experiment was repeated four times for each line. The intensities
of all genes are shown after background subtraction, normaliza-
tion, and merging of replicate culture dye-swap hybridizations.
MAANOVA statistical analysis was performed to determine genes
with significantly different mRNA expression.
(XLSX)
Table S2 Lists of genes enriched $2-fold in CYD-1/CDK-4,
CYE-1/CDK-2AF, both, or exclusively in one of the strains,
including GO-term analysis and functional classification. This file
also includes fold-change values for all significantly changed genes.
(XLSX)
Table S3 Fold change of all probes enriched in CYD-1/CDK-4
or CYE-1/CDK-2AF lines (p-value , 0.05).
(XLSX)
Table S4 Transcription-factor binding sites enriched in the
promoters of Cyclin/CDK-induced genes. Includes sequence
logos for the recognition sites of the transcription factors identified
in the promoter analysis. The Clover raw score indicates how
frequently a motif is present. For E2F sites, this score is 44 for the
set of 143 genes upregulated in CYD-1/CDK-4 animals but not in
CYE-1/CDK-2 animals, as compared to 167 6 7 on average for a
random selection of 143 genes induced by CYD-1/CDK-4 as well
as CYE-2/CDK-2AF.
(XLSX)
Table S5 Lists of genes downregulated $2-fold in CYD-1/
CDK-4, and genes upregulated $2-fold in control muscle cells
Cell Cycle Re-Entry in Differentiated Cells
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term analysis of these genes.
(XLSX)
Text S1 Supplementary Methods, Supplementary References.
(DOC)
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